Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries

Cardiovascular Research
Shmuel BanaiAlexander Levitzki

Abstract

Tyrphostin AGL-2043 is a potent tricyclic quinoxaline inhibitor of PDGF beta-receptor tyrosine kinase (PTK), Kit, and Flt3. We have shown previously that selective inhibition of PDGF beta-receptor PTK by tyrphostins markedly reduces SMC proliferation and migration in vitro, reduces neointima formation in balloon-injured porcine femoral arteries, and reduces neointimal stenosis in stented porcine coronary arteries when administered intramurally within biodegradable nanoparticles. The present study was designed to determine the effect of AGL-2043 delivered from a stent-based, biodegradable polymeric coating on neointima formation in the porcine coronary artery model. Stents coated with biodegradable, polylactic/glycolic acid (PLGA) polymer, with (n=13) or without (n=11) 180 mcg AGL-2043 were implanted into the proximal LAD of 24 Sinclair mini-pigs (34+/-4 kg) to achieve a 1.1:1 stent/artery diameter ratio. The delivery of drug from stent to tissue was confirmed by high-performance liquid chromatography. After 28 days, histomorphometric analysis showed that in-stent stenosis in animals treated with AGL-2043 was reduced by 50% (51+/-21% versus 26+/-10%, p=0.001), the absolute neointimal area was reduced by 44% (2.38+/-1.04 versus 1...Continue Reading

Citations

Feb 18, 2010·Journal of Materials Science. Materials in Medicine·N B TavakalyanA Mihranyan
Oct 12, 2005·Heart·R R Anis, K R Karsch
Jun 8, 2006·Annual Review of Biochemistry·Alexander Levitzki, Eyal Mishani
Oct 10, 2012·Annual Review of Pharmacology and Toxicology·Alexander Levitzki
Oct 29, 2010·Journal of Vascular and Interventional Radiology : JVIR·Yong-Dong LiGyungyub Gong
Apr 21, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qiongyu GuoPatrick T Mather
Dec 26, 2006·Biomaterials·Gopinath ManiC Mauli Agrawal
Jan 4, 2006·Current Problems in Cardiology·Amar M SalamDavid R Holmes
Jan 8, 2015·Therapeutic Delivery·Deepak N KapoorSanju Dhawan
Dec 22, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Amir KraitzerMeital Zilberman
Dec 2, 2010·Nature Reviews. Drug Discovery·Friedrich GrimmingerHossein A Ghofrani
May 14, 2009·Expert Review of Molecular Diagnostics·Jian-Ming LüChangyi Chen
Jan 10, 2018·Pacing and Clinical Electrophysiology : PACE·Tim VandecasteeleGlenn Van Langenhove

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioremediation (ASM)

Bioremediation is the treatment and removal of harmful pollutants or contaminants through the use of microorganisms. Discover the latest research here.